Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 44,110 shares at $435.52 ($18.9M) on 2025-11-03, disclosed to the SEC on 2025-11-04.
Scheduled sale ($18.9M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $417.50 | 7,875 | $3.3M | 17.4% |
| 2 | $417.50 | 7,875 | $3.3M | 17.4% |
| 3 | $432.55 | 964 | $417K | 2.2% |
| 4 | $432.55 | 964 | $417K | 2.2% |
| 5 | $433.52 | 2,687 | $1.2M | 6.2% |
| 6 | $433.52 | 2,687 |
| $1.2M |
| 6.2% |
| 7 | $434.68 | 2,918 | $1.3M | 6.7% |
| 8 | $434.68 | 2,918 | $1.3M | 6.7% |
| 9 | $435.52 | 3,204 | $1.4M | 7.4% |
| 10 | $435.52 | 3,204 | $1.4M | 7.4% |
| 11 | $436.45 | 2,121 | $926K | 4.9% |
| 12 | $436.45 | 2,121 | $926K | 4.9% |
| 13 | $437.70 | 890 | $390K | 2.1% |
| 14 | $438.34 | 585 | $256K | 1.4% |
| 15 | $438.34 | 585 | $256K | 1.4% |
| 16 | $439.35 | 575 | $253K | 1.3% |
| 17 | $439.35 | 575 | $253K | 1.3% |
| 18 | $440.71 | 511 | $225K | 1.2% |
| 19 | $440.71 | 511 | $225K | 1.2% |
| 20 | $441.94 | 170 | $75K | 0.4% |
| 21 | $441.94 | 170 | $75K | 0.4% |
| Total | $429.08 avg | 44,110 | $18.9M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |